This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epilepsy and osteoporosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Epilepsy and osteoporosis

A cohort study (n=6275) found both the development of epilepsy (independent of antiseizure medication [ASM] use) and use of ASM (independent of epilepsy and irrespective of enzyme-inducing capacity) were associated with increased hazards for osteoporosis (1)

  • study collected data on 6275 adults with incident adult-onset epilepsy, enrolled in the Clinical Practice Research Datalink. Analyses controlling for osteoporosis risk factors noted the following:
    • incident epilepsy was independently associated with a 41% faster time to incident osteoporosis (time ratio [TR], 0.59; 95% CI, 0.52-0.67; P<0.001)

    • both enzyme-inducing (TR, 0.91; 95% CI, 0.87-0.95; P<0.001) and non-enzyme inducing ASMs (TR, 0.77; 95% CI, 0.76-0.78; P<0.001) were associated with increased risks, independent of epilepsy, accounting for 9% and 23% faster times to development of osteoporosis, respectively

    • authors conclude, based on their findings, that routine osteoporosis screening and prophylaxis should be considered in all people with epilepsy

Previously noted (2):

  • studies have shown a significant reduction in bone mineral density (BMD) and an increased fracture risk in patients treated with enzyme-inducing antiepileptics (phenobarbital, carbamazepine, phenytoin)
    • assumed that CYP450-inducing antiepileptic drugs (AEDs) upregulate the enzymes which are responsible for vitamin D metabolism, with the effect of converting 25(OH) vitamin D into inactive metabolites, resulting in reduced calcium absorption with consecutive secondary hyperparathyroidism
    • for patients with long-term AED exposure, BMD measurement is recommended as part of osteoporosis investigation (especially for patients treated with enzyme-inducing AEDs and where there are major risk factors for fractures)

Reference


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.